These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
422 related items for PubMed ID: 16450335
1. The HAUSP gene plays an important role in non-small cell lung carcinogenesis through p53-dependent pathways. Masuya D, Huang C, Liu D, Nakashima T, Yokomise H, Ueno M, Nakashima N, Sumitomo S. J Pathol; 2006 Apr; 208(5):724-32. PubMed ID: 16450335 [Abstract] [Full Text] [Related]
2. Reduced ING1b gene expression plays an important role in carcinogenesis of non-small cell lung cancer patients. Kameyama K, Huang CL, Liu D, Masuya D, Nakashima T, Sumitomo S, Takami Y, Kinoshita M, Yokomise H. Clin Cancer Res; 2003 Oct 15; 9(13):4926-34. PubMed ID: 14581367 [Abstract] [Full Text] [Related]
3. Topoisomerase IIalpha gene expression is regulated by the p53 tumor suppressor gene in nonsmall cell lung carcinoma patients. Liu D, Huang CL, Kameyama K, Hayashi E, Yamauchi A, Sumitomo S, Yokomise H. Cancer; 2002 Apr 15; 94(8):2239-47. PubMed ID: 12001123 [Abstract] [Full Text] [Related]
7. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer. Huang C, Taki T, Adachi M, Konishi T, Higashiyama M, Miyake M. Oncogene; 1998 May 14; 16(19):2469-77. PubMed ID: 9627113 [Abstract] [Full Text] [Related]
8. Associations of MDM2 SNP309, transcriptional activity, mRNA expression, and survival in stage I non-small-cell lung cancer patients with wild-type p53 tumors. Chien WP, Wong RH, Cheng YW, Chen CY, Lee H. Ann Surg Oncol; 2010 Apr 14; 17(4):1194-202. PubMed ID: 19941079 [Abstract] [Full Text] [Related]
11. p53 apoptotic pathway molecules are frequently and simultaneously altered in nonsmall cell lung carcinoma. Mori S, Ito G, Usami N, Yoshioka H, Ueda Y, Kodama Y, Takahashi M, Fong KM, Shimokata K, Sekido Y. Cancer; 2004 Apr 15; 100(8):1673-82. PubMed ID: 15073856 [Abstract] [Full Text] [Related]
13. Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression. Gorgoulis VG, Zacharatos P, Kotsinas A, Liloglou T, Kyroudi A, Veslemes M, Rassidakis A, Halazonetis TD, Field JK, Kittas C. Am J Pathol; 1998 Dec 15; 153(6):1749-65. PubMed ID: 9846966 [Abstract] [Full Text] [Related]
14. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression. Vonlanthen S, Heighway J, Tschan MP, Borner MM, Altermatt HJ, Kappeler A, Tobler A, Fey MF, Thatcher N, Yarbrough WG, Betticher DC. Oncogene; 1998 Nov 26; 17(21):2779-85. PubMed ID: 9840942 [Abstract] [Full Text] [Related]
16. Overexpression of bax associated with mutations in the loop-sheet-helix motif of p53. Huang C, Kohno N, Inufusa H, Kodama K, Taki T, Miyake M. Am J Pathol; 1999 Sep 26; 155(3):955-65. PubMed ID: 10487853 [Abstract] [Full Text] [Related]
18. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions. Ruggeri BA, Huang L, Berger D, Chang H, Klein-Szanto AJ, Goodrow T, Wood M, Obara T, Heath CW, Lynch H. Cancer; 1997 Feb 15; 79(4):700-16. PubMed ID: 9024708 [Abstract] [Full Text] [Related]
19. Expression of inhibitors of apoptosis (IAP) proteins in non-small cell human lung cancer. Hofmann HS, Simm A, Hammer A, Silber RE, Bartling B. J Cancer Res Clin Oncol; 2002 Oct 15; 128(10):554-60. PubMed ID: 12384799 [Abstract] [Full Text] [Related]